A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
Status: | Completed |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/14/2017 |
Start Date: | July 2007 |
End Date: | October 2011 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease
1) To evaluate the effectiveness of AST-120 (spherical carbon adsorbent) added to
standard-of-care therapy in moderate to severe Chronic Kidney Disease (CKD), on time to first
occurrence of any event of the triple composite outcome of initiation of dialysis, kidney
transplant or doubling of serum creatinine (sCr) when compared with placebo; 2) To evaluate
the safety and tolerability of long-term AST-120 therapy in patients with CKD; 3) To evaluate
the effects of AST-120 versus placebo, on other measures of renal function.
standard-of-care therapy in moderate to severe Chronic Kidney Disease (CKD), on time to first
occurrence of any event of the triple composite outcome of initiation of dialysis, kidney
transplant or doubling of serum creatinine (sCr) when compared with placebo; 2) To evaluate
the safety and tolerability of long-term AST-120 therapy in patients with CKD; 3) To evaluate
the effects of AST-120 versus placebo, on other measures of renal function.
Inclusion Criteria:
- Age 18 years or older
- Moderate to severe CKD, not anticipated to require dialysis or renal transplant within
the next 6 months
- Patient survival expected to be no less than one year
- Serum creatinine in men >= 2.0 mg/dL (>= 177 µmol/L) and <= 5.0 mg/dL (<= 442 µmol/L),
and in women >= 1.5 mg/dL (>= 133 µmol/L) and <= 5.0 mg/dL (<= 442 µmol/L) at
Screening
- Urinary total protein to urinary total creatinine ratio must be >= 0.5 on a spot void
at Screening
- Blood pressure <= 160/90 mmHg at both Screening and Baseline. In addition, blood
pressure, if measured, must have been stable in hypertensive patients over the 3
months prior to Screening, with no more than 1 blood pressure reading > 160/90 mmHg
- In patients being treated for hypertension, they should be on a stable
anti-hypertensive regimen
Exclusion Criteria:
- Obstructive or reversible cause of kidney disease
- Nephrotic syndrome defined as a ratio of urinary total protein to urinary creatinine
of > 6.0 as measured on a spot void
- Adult polycystic kidney disease
- History of previous kidney transplant
- History of recent (within the past 6 months) accelerated or malignant hypertension
- Uncontrolled arrhythmia or severe cardiac disease within the past 6 months
- History of malabsorption, inflammatory bowel disease, hiatal hernia, active peptic
ulcer, or severe GI dysmotility, not attributable to the use of a phosphate binder
- Received any investigational agent or participated in a clinical study within the
previous 3 months
- Presence of any significant medical condition that might create an undue risk with
study participation, or significantly confound the collection of safety and efficacy
data in this study
We found this trial at
42
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials